Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...

Abbott today officially opened its new diabetes technology manufacturing facility in Kilkenny, Ireland. The site will employ ...

But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

US medical technology firm Abbott has opened its new diabetes monitoring device manufacturing facility in Kilkenny that will ...

The site is a global manufacturing centre of excellence for Abbott’s diabetes care business and will employ more than 800 ...

“This state-of-the-art Kilkenny facility will have the highest production of Libre sensors in the world to help meet the ...

The new facility is part of a €440m investment made by Abbott in Ireland. The initial announcement was made back in 2022.

US medtech giant Abbott has officially opened a new manufacturing facility in Kilkenny, which will employ 800 people. The ...